Terms and Conditions

Goodcap Pharmaceuticals Inc.

Website Terms and Conditions 

Last Updated:  April 26, 2021  

This website (the “Site”) and the information it offers including any webpages, text, images, sounds, software, and other data or information contained in the Site (the “Content”) are owned and operated by Goodcap Pharmaceuticals Inc. (“Goodcap”, we”, “our” and “us”, including, where applicable, any affiliate of Goodcap). These Terms and Conditions are a binding agreement that applies to use of the Site generally, including reviewing Content. 

Not Medical Advice:  The Site, including the Content, is provided for general informational purposes only, and does not constitute any representation as to the safety, efficacy, suitability, effectiveness or other features of natural health products such as mushrooms and their ingredients including psilocybin to antioxidants like selenium and glutathione, or any other product in the management of any medical condition or for any purpose, and is not intended to provide, or to be a substitute for, professional medical advice.  

ALWAYS SEEK THE ADVICE OF A PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PRACTITIONER FOR ANY QUESTIONS YOU MAY HAVE ABOUT ANY ILLNESS OR OTHER CONDITION, INCLUDING THE SUITABILITY OR EFFECTIVENESS OF ANY PARTICULAR COURSE OF TREATMENT. NEVER DISREGARD ANY PROFESSIONAL MEDICAL ADVICE BECAUSE OF ANYTHING YOU READ ON THE SITE. 

IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL 911 OR A PHYSICIAN IMMEDIATELY 

Access is Agreement to these Terms and Conditions:  These Terms and Conditions are a binding agreement between you and Goodcap. These Terms and Conditions apply to your access to and use of the Site, including any review of the ContentThese Terms and Conditions include disclaimers, exempt Goodcap and other persons from liability, indemnify Goodcap and other persons, and include other important provisions. You must read these Terms and Conditions and any information linked to or otherwise referenced in these Terms and Conditions, and accept these Terms and Conditions, before using the Site.  

YOUR ACCESS TO OR OTHER USE OF THE SITE, INCLUDING REVIEWING ANY CONTENT, OR ANY OTHER USE OF THE SITECONSTITUTES YOUR ACCEPTANCE OF AND AGREEMENT TO THE THESE TERMS AND CONDITIONS AS MOST RECENTLY UPDATED. 

IF YOU DO NOT AGREE TO THESE TERMS AND CONDITIONS, YOU MAY NOT ACCESS OR USE THE SITE IN ANY WAYINCLUDING REVIEWING ANY CONTENT. 

IF YOU HAVE ANY QUESTIONS OR CONCERNS ABOUT THESE TERMS AND CONDITIONS PLEASE CONTACT info@Goodcapwellness.com 

Updates to the Terms and Conditions:  Goodcap may in its discretion revise, modifychange or otherwise update these Terms and Conditions at any time. Your continued use of the Site after any modification of these Terms and Conditions constitutes your acceptance of and agreement with the Terms and Conditions as updated. A notification of any update to the Terms and Conditions will be posted on the Site home page 60 days prior to the change. Where required by Applicable Law as defined below in these Terms and Conditionsyou will be notified by email or other method at contact information you have supplied for any newsletter, opt-in communication, or otherwise, if and when these Terms and Conditions are updated. 

Regulations and Other Applicable Law:  The Site and the Content relate in part to natural health productsNatural health products, are regulated in Canada by legislation including the Food and Drug Act (Canada) (the “Act”) and the Natural Health Product Regulations (Canada) (the “NHPR”).  Other federal, provincial or local law may apply to some aspects of the Site and ContentAs used herein the term “Applicable Law” includes the Act, the NHPR and any other applicable federal, provincial or local law as may be appropriate in the context, including consumer protection legislation, privacy legislation, other statutory law and regulations, the Civil Code of Québec, common law, and any other applicable laws. Applicable Law may, as appropriate in the context, define the rights and liabilities, subject to the disclaimers, limitations of liability, and other provisions of these Terms and Conditions, of you, Goodcap or other persons. 

Eligibility based on Residence and Age:  The Site is intended for access, review, or other use by residents of Canada, and is not intended for access, review or other use by minor without supervision and guidance by a parent or legal guardian. For the purposes of these Terms and Conditions, a “minor” is someone who has not reached both:  (a) the age eighteen, and (b) the age of majority in the applicable jurisdiction from which the Site is being accessed. If you are a minor, you are not permitted to access, review or otherwise use the Site without supervision by and guidance of a parent or legal guardian 

GOODCAP MAKES NO REPRESENTATION OR WARRANTY THAT THE SITE, OR THE CONTENT ARE APPROPRIATE OR AVAILABLE FOR ACCESS OR OTHER USE IN ALL LOCATIONS AND JURISDICTIONSIF YOU ARE ACCESSING OR USING THE SITE FROM OUTSIDE OF CANADA, REVIEWING CONTENT (INCLUDING ANY PUBLICLY-AVAILABLE OR LOGIN-ONLY CONTENT, OR OTHERWISE USING THE SITE, IT IS SOLELY YOUR RESPONSIBILITY TO ENSURE THAT ANY SUCH ACCESS OR USE COMPLIES WITH APPLICABLE LAWS OF ANY KIND WHATSOEVER IN THE JURISDICTION FROM WHICH YOU ARE ACCESSING OR USING THE SITE. 

Using the Site:  You may view and print Content from the Site for personal, informational, and non-commercial use. You may not otherwise copy, reproduce, modify, collect, republish, distribute, or catalogue any Content without Goodcap’s express written consent. Without limiting the generality of the foregoing, you may not use the Site or any Content for commercial purposes without Goodcap’s express written consent. 

Prohibited Use of the Site:  You may not use the Site or any Content for any unlawful purpose or any unsafe purposeAccessing or using the Site, including reviewing Content, acting on Content, or otherwise using the Site in jurisdictions where the Site or the Content are illegal, is prohibited. If you choose to access the Site from such a jurisdiction, you do so on your own initiative, discretion and risk, and you are responsible for compliance with both the Applicable Law and with any laws applicable in the jurisdiction from which you are accessing the SiteWithout limiting the generality of the foregoing, while accessing or using the Site, including reviewing Content, you agree that you will not: 

  1. violate any laws, including the Applicable Lawany third party rights or our policies; 

  1. access or use the Site if you are not able to form legally binding contracts, are under the age of majority in your province or territory of residence, or are temporarily or indefinitely suspended from accessing or using the Site; 

  1. access or use the Site in any manner which could damage, disable, overburden or impair the Site; 

  1. interfere with the security of, or otherwise abuse, the Siteor any system resources, accounts, servers or networks connected to or accessible through the Site or affiliated or linked sites; 

  1. distribute viruses or any other technologies that may harm or prejudice the interests, rights, or property of Goodcap or of any other person accessing or using the Site; 

  1. use any robot, spider or other automatic device, to index, crawl, catalogue, mirror, frame, scrape, cache or otherwise monitor or copy any web page of the Site or any Content to collect or mine data from the Site 

  1. use any manual process to monitor or copy any web page of the Site or any Content other than as provided for in these Terms and Conditions; 

  1. obtain unauthorized access to the Site or portions of the Site that are restricted from general access; 

  1. copy, modify or distribute rights or Content from the Site, including Content subject to copyright and common law or registered trademark rights owned by or licensed to, without limitation, Goodcap, and whether or not for consideration or for commercial purposes 

  1. harvest or otherwise collect information about any user of the Siteincluding email addresses, without their consent and compliance with all Applicable Law; or 

  1. attempt to complete any of the above actions. 

Without limiting other recourse, including but not limited to any remedy available under Applicable Law, we may limit, delay, suspend or terminate any access to the Site, Content, linked sites, deny an Application, or take technical and legal steps to keep users off the Site if we believe, in our discretion, that the user is creating problems or possible legal liabilities, infringing the intellectual property rights of Goodcap or third parties, or otherwise acting inconsistently with the letter or spirit of these Terms and Conditions or our policies, or otherwise to the determinant of GoodcapGoodcap Group (as defined below in these Terms and Conditions), or any other person.  

No Spam, Spyware or Spoofing:  Goodcap  takes compliance with Applicable Law pertaining to commercial electronic messages, including but not limited to Canadian Anti-Spam Legislation (CASL), very seriously. We will not send you commercial electronic messages without consent as set forth in CASL. For example, you may choose to receive a newsletter or other commercial electronic messages from Goodcap on an opt-in basis, and having done so may opt out at any time. You may not use our communication tools or the Site more broadly to distribute spam, distribute or leverage spyware, or otherwise send content that would violate these Terms and Conditions or any Applicable Law 

Accuracy of Site Content:  All Content is provided on an “as is” basis for informational purposes only and is subject to change without notice. While the Site and the Content are regularly updated, the Content may be inaccurate, out-of-date, or otherwise incorrect. Goodcap assumes no liability or responsibility for any such errors, omissions or inaccuracies and makes no representations about the accuracy, reliability, completeness, or timeliness of the Content. Without limiting the generality of the foregoing, and subject to the limitations on liability disclaimers included in these Terms and Conditions, Goodcap does not:  (amake any representation or warranty regarding the accuracy, completeness, or usefulness of the Content, or (b) adopt, endorse, or accept responsibility for the accuracy or reliability of any opinion, advice, or statement made by Goodcap or by any third party, which appears on the Site. Subject to the foregoing, Goodcap works to keep the Site updated and working properly. Please report any perceived problems, perceived offensive or inappropriate Content, and any perceived policy violations to us by email at info@Goodcapwellness.com 

Content and Intellectual Property RightsThe Site and all Content, including these Terms and Conditions are © 2021 Goodcapits suppliers or affiliates. All rights reserved. The copyright for the Site and all Content is owned by or licensed to Goodcap and is protected under Applicable Law including the Copyright Act (Canada), common law rights, and by other copyright laws in other jurisdictions. No Content may be reproduced, adapted, uploaded to a third party, linked to, framed, performed in public, distributed or transmitted in any form by any process without the specific written consent of Goodcap, other than as expressly provided for in these Terms and Conditions. Nothing on the Site shall be construed as conferring any transfer of rights to you of any intellectual property or other proprietary or exclusionary rights of Goodcap or any third party, whether by estoppel, by implication or otherwise, and whether defined by statute, including any ownership or other rights related to pending or issued applications for patents, trademark registrationsregistered plant breeder’s rights, copyright registrations, or by common law, including any rights in copyright, goodwill, trademark, branding, trade secret, or confidential information (collectively, “Intellectual Property Rights”). 

Trademarks:  Without limiting the generality of the foregoing, the product names, company names and logos of Goodcapany affiliate or any third party used on the Site may be trademarks, including registered trademarks of Goodcap. Such trademarks, product names, company names or logos may not be copied, imitated or used, in whole or in part, without the prior written consent of Goodcap or any owners or other relevant parties as applicable relating to the trademarks, product names, company names or logos. 

Reservation of Rights:  Without limiting the generality of the foregoing, other of Goodcap’s methods and processes may be subject to rights, including Intellectual Property Rights, of Goodcap or a third partyGoodcap and any applicable third parties reserve all such rights. 

Privacy:  By using the Site, including by reviewing the Content, subscribing to a newsletter or other opt-in communication, you consent to the collection, use, disclosure and retention of your personal information by or on behalf of Goodcap as explained in the Goodcap Privacy Policy www.goodcapwellness.com/privacy, as revised from time to time, and as otherwise permitted or required by Applicable Law. 

Confidentiality:  Electronic communications, including over the internet and through email, are not secure means of communication and the privacy, integrity or authenticity of any communication over the Internet with you shall not expose Goodcap to any liability for damages you may suffer as a result of communicating with Goodcap by electronic communications or if Goodcap communicates such information to you at your request, including in the context of an Application.  

Outbound Links:  The Site may contain links to third-party websites and resources. These linked websites are provided solely as a convenience to you, and not as an endorsement by Goodcap of the third-party websites or resources, or of any product or services offered or endorsed by such third partiesGoodcap makes no representations or warranties regarding the availability, correctness, accuracy, performance or quality of any linked website or any content, software, service or application found at any linked website.  

Inbound Links:  You agree not to link to the Site in association with any false, inaccurate, misleading, misappropriated, defamatory or libelous content, in association with any spam, unsolicited or bulk electronic messages, including commercial electronic messagesSubject to these Terms and Conditions, Goodcap generally agrees with linking to the Site through link, including a plain text link or logo link, without an additional written agreement between yourself and GoodcapNotwithstanding the foregoing, Goodcap reserves the right to require that you remove any link from a website owned, operated, posted on or otherwise used by you to publish a reference to the Site through a link, at Goodcap’s discretionincluding for posting any link in association with, displayed with, or in any way connected with the Site, Goodcap, or Goodcap Group (as defined below in these Terms and Conditions). 

No Agency:  No agency, partnership, joint venture, employee-employer or franchiser-franchisee relationship is intended or created by these Terms and Conditions. 

GOODCAP GROUP:  THE FOLLOWING DISCLAIMERS, LIMITATION OF LIABILITY AND INDEMNIFICATION PROVISIONS REFERENCE AND APPLY TO GOODCAP, INCLUDING ALL AFFILIATES OF OR ENTITIES RELATED TO GOODCAP PHARMACEUTICALS INC, AND ANY OFFICERS, DIRECTORS, EMPLOYEES, OR AGENTS OF GOODCAP PHARMACEUTICALS INC., OR OF ANY AFFILIATE OR RELATED ENTITY, ANY OF THE FOREGOING ALONE OR IN ANY COMBINATION (COLLECTIVELY, THE GOODCAP GROUP”) 

DISCLAIMER:  TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW THE SITE, AND THE CONTENT ARE PROVIDED “AS IS”, WITHOUT REPRESENTATION, WARRANTY OR CONDITION OF ANY KIND BY GOODCAP GROUP, EITHER EXPRESS OR IMPLIED. WITHOUT LIMITING THE FOREGOING, GOODCAP GROUP EXPRESSLY DISCLAIMS ANY WARRANTIES OR CONDITIONS OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, QUIET ENJOYMENT OR NON-INFRINGEMENT, AND ANY WARRANTIES ARISING OUT OF THE COURSE OF DEALING OR USAGE OF TRADE. GOODCAP GROUP MAKES NO WARRANTY THAT THE SITE, OR THE CONTENT WILL MEET YOUR REQUIREMENTS OR BE AVAILABLE ON AN UNINTERRUPTED, SECURE, OR ERROR-FREE BASIS. GOODCAP GROUP MAKES NO WARRANTY REGARDING THE QUALITY OF THE SITE, THE CONTENT, OR THE ACCURACY, TIMELINESS, TRUTHFULNESS, COMPLETENESS OR RELIABILITY OF ANY CONTENT ON THE SITE. WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, NO STATEMENTS BY GOODCAP GROUP OR ANY PERSON ON THE SITE SHALL BE INTERPRETED AS A STATEMENT THAT ANY PRODUCT IS A THERAPEUTIC PRODUCT AS DEFINED IN THE FOOD AND DRUGS ACT (CANADA) 

DISCLAIMER OF GOODCAP GROUP COMMUNICATIONS:  NO ADVICE OR INFORMATION, WHETHER ORAL OR WRITTEN, OBTAINED THROUGH THE SITE OR OTHERWISE FROM GOODCAP GROUP, CREATES ANY WARRANTY OR CONDITION OTHER THAN AS EXPRESSLY MADE IN THESE TERMS AND CONDITIONS OR AS REQUIRED BY APPLICABLE LAW 

DISCLAIMER OF THIRD PARTY STATEMENTS:  YOU ARE SOLELY RESPONSIBLE FOR ALL OF YOUR COMMUNICATIONS AND INTERACTIONS WITH OTHER USERS OF THE SITE, AND WITH OTHER PERSONS WITH WHOM YOU COMMUNICATE OR INTERACT AS A RESULT OF YOUR USE OF THE SITEOR THE CONTENT. YOU UNDERSTAND THAT GOODCAP GROUP DOES NOT ATTEMPT TO VERIFY THE STATEMENTS MADE BY OTHER PERSONS ABOUT THE SITE, THE CONTENT, OR GOODCAP GROUP.  

FORWARD-LOOKING INFORMATION 

THIS SITE MAY CONTAIN CERTAIN INFORMATION THAT IS FORWARD-LOOKING AND IS SUBJECT TO IMPORTANT RISKS AND UNCERTAINTIES. THE WORDS “ANTICIPATE”, “EXPECT”, “BELIEVE”, “MAY”, “SHOULD”, “ESTIMATE”, “PROJECT”, “OUTLOOK”, “FORECAST” OR OTHER SIMILAR WORDS ARE USED TO IDENTIFY SUCH FORWARD-LOOKING INFORMATION. FORWARD-LOOKING STATEMENTS IN THIS SITE ARE INTENDED TO PROVIDE GOODCAP SECURITY HOLDERS AND POTENTIAL INVESTORS WITH INFORMATION REGARDING GOODCAP AND ITS SUBSIDIARIES, INCLUDING MANAGEMENT’S ASSESSMENT OF GOODCAP‘S FINANCIAL AND OPERATIONS PLANS AND OUTLOOK.  FORWARD-LOOKING STATEMENTS IN THE INVESTOR RELATIONS MATERIALS ON THIS SITE MAY INCLUDE, AMONG OTHERS, STATEMENTS REGARDING THE ANTICIPATED BUSINESS PROSPECTS AND FINANCIAL PERFORMANCE OF GOODCAP AND ITS SUBSIDIARIES, EXPECTATIONS OR PROJECTIONS ABOUT THE FUTURE, AND STRATEGIES AND GOALS FOR GROWTH AND EXPANSION.  ALL FORWARD-LOOKING STATEMENTS REFLECT GOODCAP‘S BELIEFS AND ASSUMPTIONS BASED ON INFORMATION AVAILABLE AT THE TIME THE STATEMENTS WERE MADE.  ACTUAL RESULTS OR EVENTS MAY DIFFER FROM THOSE PREDICTED IN THESE FORWARD-LOOKING STATEMENTS. FACTORS THAT COULD CAUSE ACTUAL RESULTS OR EVENTS TO DIFFER MATERIALLY FROM CURRENT EXPECTATIONS INCLUDE, AMONG OTHERS, THE ABILITY OF GOODCAP TO SUCCESSFULLY IMPLEMENT ITS STRATEGIC INITIATIVES AND WHETHER SUCH STRATEGIC INITIATIVES WILL YIELD THE EXPECTED BENEFITS, AND OTHER NATURAL HEALTH PRODUCT INDUSTRY ISSUES.  BY ITS NATURE, FORWARD LOOKING INFORMATION IS SUBJECT TO VARIOUS RISKS AND UNCERTAINTIES, WHICH COULD CAUSE GOODCAP‘S ACTUAL RESULTS AND EXPERIENCE TO DIFFER MATERIALLY FROM THE ANTICIPATED RESULTS OR EXPECTATIONS EXPRESSED.  READERS ARE CAUTIONED TO NOT PLACE UNDUE RELIANCE ON THIS FORWARD LOOKING INFORMATION, WHICH IS GIVEN AS OF THE DATE IT IS EXPRESSED IN THIS SITE OR OTHERWISE, AND TO NOT USE FUTURE-ORIENTED INFORMATION OR FINANCIAL OUTLOOKS FOR ANYTHING OTHER THAN THEIR INTENDED PURPOSE. GOODCAP UNDERTAKES NO OBLIGATION TO UPDATE PUBLICLY OR REVISE ANY FORWARD-LOOKING INFORMATION, WHETHER AS A RESULT OF NEW INFORMATION, FUTURE EVENTS OR OTHERWISE, EXCEPT AS REQUIRED BY LAW. 

LIMITATION OF LIABILITY:  YOU EXPRESSLY UNDERSTAND AND AGREE THAT TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, GOODCAP GROUP IS NOT AND SHALL NOT BE HELD RESPONSIBLE OR LIABLE TO YOU OR ANY PERSON FOR ANY CLAIM OR REMEDY WHATSOEVER INCLUDING ANY CLAIM FOR, OR REMEDY INCLUDING, DAMAGES, EQUITABLE RELIEF, INJUNCTIVE RELIEF, OR OTHER REMEDY, INCLUDING ANY DIRECT, INDIRECT, SPECIAL, INCIDENTAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES, INCLUDING REMEDIES FOR ANY ADVERSE REACTION, PERSONAL INJURY (INCLUDING DEATH)LOSS OF USE, DISCLOSURE OR LOSS OF DATA, LOST PROFITS, BREACH OF CONFIDENCE, LEGAL, FINANCIAL OR OTHER PROFESSIONAL FEES, CONSULTING FEES, OR OTHER INTANGIBLE LOSSES, WHATSOEVER AND HOWSOEVER CAUSED, REGARDLESS OF THE THEORY OF LAW PROVIDING A BASIS FOR THE REMEDY (INCLUDING CONTRACT, TORT, OR STATUTE), FOR ANY LOSS ARISING OUT OF OR IN ANY WAY CONNECTED WITH  

(A) YOUR USE OR APPLICATION OF THE SITE, OR THE CONTENT;  

(B) YOUR INABILITY TO USE OR APPLY THE SITE OR THE CONTENT; 

(C) YOUR USE OF OR RELIANCE ON ANY CONTENT OR OTHER INFORMATION DISPLAYED ON, HOSTED ON, CONTAINED ON, OR OTHERWISE ACCESSIBLE THROUGH THE SITE; 

(D) WITH THE SELECTION, ADOPTION OR IMPLEMENTATION OF ANY PARTICULAR COURSE OF TREATMENT FOR ANY ILLNESS OR CONDITION; 

(EANY MISUSE OF THE SITE BY YOU OR OTHER PERSONS, INCLUDING IN CONTRAVENTION OF THESE TERMS AND CONDITIONS; OR 

(F) ANY OTHER MATTER RELATED TO THE SITE. 

IF YOU CHOOSE TO USE THE SITE OR THE CONTENT, YOU DO SO AT YOUR DISCRETION AND RISK, AND WITHOUT ANY RECOMMENDATION TO DO SO FROM GOODCAP GROUP. YOU EXPRESSLY REPRESENT AND WARRANT THAT YOU ARE ACCESSING, APPLYING AND USING THE SITE, AND THE CONTENT, ONLY UNDER THE ADVICE OF A PHYSICIAN OR OTHER HEALTH CARE PRACTITIONER IN ACCORDANCE WITH APPLICABLE LAW AND OTHERWISE AT YOUR OWN RISK AND UNDER YOUR OWN DISCRETION. 

THIS LIMITATION OF LIABILITY APPLIES NOTWITHSTANDING, AS APPLICABLE (A) ANY POTENTIAL LIABILITY HAVING BEEN REASONABLY FORESEEABLE, (B) ANY ERROR OR OMISSION BY GOODCAP GROUP OR IN THE CONTENT WHETHER OR NOT GOODCAP GROUP KNEW OR OUGHT TO HAVE KNOWN OF, OR WERE OTHERWISE RESPONSIBLE FOR, ANY SUCH ERROR OR OMISSION, (CGOODCAP GROUP HAVING BEEN INFORMED OF THE POSSIBILITY OF POTENTIAL LIABILITY, OR (DOTHER REMEDIES NOT BEING AVAILABLE OR NOT ADEQUATELY COMPENSATING YOU OR ANY OTHER PERSON. 

INDEMNITY:  YOU AGREE TO RELEASE, DEFEND, INDEMNIFY, AND HOLD GOODCAP GROUP HARMLESS FROM AND AGAINST ANY AND ALL CLAIMS AND REMEDIES BROUGHT BY A THIRD PARTY ARISING FROM OR RELATED TO ANY USE OF THE SITE AND THE CONTENT. NOTWITHSTANDING THIS INDEMNITY, GOODCAP GROUP RETAINS THE RIGHT TO PARTICIPATE IN THE DEFENSE AND SETTLEMENT NEGOTIATIONS RELATING TO THE FOREGOING WITH COUNSEL OF GOODCAP’S SELECTION AT GOODCAP GROUP’S DISCRETION, AND SOLE COST AND EXPENSE.  

DISCLAIMER ON EXPERIMENTAL FEATURES INCLUDING BETA FEATURES:  FROM TIME TO TIME, NEW FEATURES THAT MAY BE ACCESSED FROM THE SITE FOR TESTING AND EXPERIMENTATION BY YOU MAY BE PROVIDED, INCLUDING BETA FEATURES. SUCH NEW FEATURES ARE OFFERED SOLELY FOR EXPERIMENTAL PURPOSES AND WITHOUT ANY REPRESENTATIONS, WARRANTIES, OR CONDITIONS OF ANY KIND, WHETHER EXPRESS, IMPLIED OR COLLATERAL, AND MAY BE MODIFIED OR DISCONTINUED AT GOODCAP’S DISCRETION. THE PROVISIONS OF THIS AGREEMENT, INCLUDING ANY LIABILITY DISCLAIMER, APPLY TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW TO SUCH FEATURES.  

ACKNOWLEDGEMENT:  THE PARTIES TO THESE TERMS AND CONDITIONS ACKNOWLEDGE AND AGREE THAT THESE LIMITATIONS ON LIABILITY ARE REASONABLE IN THE CIRCUMSTANCES. 

LIMITATION ON QUANTUM:  NOTWITHSTANDING THE FOREGOING, IF WE ARE FOUND TO BE LIABLE, THE QUANTUM OUR LIABILITY TO YOU OR TO ANY OTHER PERSON IS LIMITED TO THE TOTAL FEES PAID TO US BY YOU IN THE 12 MONTHS PRIOR TO THE ACTION GIVING RISE TO THE LIABILITY, TO A MAXIMUM OF $200. 

RESERVATION:  SOME JURISDICTIONS DO NOT ALLOW THE DISCLAIMER OF WARRANTIES OR CONDITIONS, OR EXCLUSION OF DAMAGES, SO SUCH DISCLAIMERS AND EXCLUSIONS MAY NOT APPLY TO YOU IF YOU MEET THE REQUIREMENTS TO BENEFIT FROM THE LAWS OF SUCH JURISDICTION NOTWITHSTANDING THESE TERMS AND CONDITIONS. 

Notices:  Except as expressly stated otherwise, providing an email address or other information to Goodcap, constitutes your consent to receive any legal notices required by Applicable Law at the an email address or other contact information you provide to Goodcap. Any Legal Notice sent by email or other electronic communication in this manner shall be deemed to have been received 24 hours after the email or other electronic communication is sent by Goodcap, unless Goodcap is notified that the email address is invalid. Alternatively, we may give you legal notice by mail at any physical address you have provided to Goodcap. In such case, notice shall be deemed given three days after the notice is sent in the mail by Goodcap. 

Legal Disputes:  To the maximum extent permitted by Applicable Law, unless Goodcap agrees otherwise, any claim, dispute or controversy, whether based on a legal theory including, contract, tort, statute or regulation, and whether including a claim for pre-existing, present or future remedies, arising out of or relating the Site, the Content these Terms and Conditions or the Privacy Policy, in any contextwill be determined by final and binding arbitration to the exclusion of the courts. Arbitration will be conducted in the city of Calgary on a simplified and expedited basis by one arbitrator pursuant to the Arbitration Act (Alberta) or the International Commercial Arbitration Act (Alberta). The foregoing does not, however, preclude Goodcap from seeking injunctive relief when necessary, as determined by Goodcap in its discretion, to protect its interests. You agree that any dispute resolution proceedings will be conducted only on an individual basis and not in a class, consolidated or representative action. If for any reason a Claim proceeds in court rather than in arbitration, you waive any right to a jury trial. 

Law and Forum for Legal Disputes:  For residents of Québec:  These Terms and Conditions will be interpreted in accordance with the laws of the Québec and the federal laws of Canada applicable therein, without regard to conflict-of-law provisions. You agree that to the extent any claim or dispute you may have against Goodcap is resolved in Court, the claim or dispute must be resolved exclusively by a Provincial Court or Federal Court located in Québec. You agree to submit to the personal jurisdiction of the courts located within Québec for the purpose of litigating all such claims or disputesFor residents of provinces outside of Québec:  These Terms and Conditions shall be governed in all respects by the laws of Alberta and the applicable federal laws of Canada, without regard to conflict of law provisions. You agree that to the extent any claim or dispute you may have against Goodcap is resolved in Court, the claim or dispute must be resolved exclusively by a Provincial Court or Federal Court located in Alberta. You agree to submit to the personal jurisdiction of the courts located within Alberta for the purpose of litigating all such claims or disputes.  

Additional Terms and Conditions:  When reviewing Content or otherwise accessing the Site, you are subject to any posted policies or rules applicable to the Site, which are available on the applicable portion of the Site Subject to any additional policies or rules, these Terms and Conditions constitute the entire agreement between you and Goodcap with respect to the Site, the Content, and any information obtained through the Site by communication with Goodcap personnel. 

Term and Termination:  These Terms and Conditions will become effective upon your acceptance of these Terms and Conditions as updated from time to time by your use of the SiteThese Terms and Conditions will remain in full force and effect unless and until updated or terminated hereunder. You acknowledge that Goodcap has the right, in its discretion, to terminate or suspend your access to the Site, or to limit or deny your access to or participation in any Content, offered by Goodcap at any time without notice to you and without liability to you or any person, if you violate or threaten to violate any of these Terms and Conditionsif you violate or threaten to violate any rights of Goodcap, interfere with any other person’s access to or use of the Site, or if Goodcap decides in its discretion for any reason whatsoever access to the Site by any person, access to Content by any person, is otherwise detrimental to the Site, Goodcap or Goodcap Group more broadlyor Goodcap’s suppliers or licensors. If you believe that someone has violated these Terms and Conditionsplease contact Goodcap with detailsGoodcap may decide, in its discretion, to investigate the report and decide, in its discretion, to take any action relating to that report. Goodcap does not have any obligation or liability to you for the performance or non-performance of those activities and has no obligation to communicate any decision or action taken as a result of your communication with Goodcap. 

Interpretation:  In these Terms and Conditions, (a) headings are for reference purposes only and do not limit the scope or extent of such section; (b) words importing the singular number only also include the plural, and vice versa; (c) “person” includes an individual, corporation and any other legal entity; (d) “including” or “includes” means including or includes (as applicable) without limitation or restriction; (e) “law” includes common law, equity, statutes and regulations; and (f) “discretion” mean a person’s sole, absolute and unfettered discretion. 

General:  You can communicate with Goodcap by email as indicated in these Terms and ConditionsYou can communicate with Goodcap by mail at info@goodcap.com . If any provision of these Terms and Conditions is held to be invalid or unenforceable, such provision shall be struck and the remaining provisions shall be enforced. Our failure to act with respect to a breach by you or others does not waive our right to act with respect to subsequent or similar breaches. We do not guarantee we will take action against all breaches of these Terms and Conditions. 

Language:  You and Goodcap have each expressly requested and required that these Terms and Conditions and all related notices and other documents be drawn up in the English language. Les parties conviennent et exigent expressément que ce Contrat et tous les documents qui s’y rapportent soient rédigés en anglaisSubject to Applicable Law, any non-English translation of these Terms and Conditions provided by Goodcap is for convenience only, and if there is a conflict or inconsistency between the English version and a non-English version then the English version of these Terms and Conditions will take priority and govern. 

If you have any questions, comments or concerns about these Conditions, please contact Goodcap’s Administration Officer by email at info@Goodcapwellness.com or by mail at the address above with attention to the Administration Officer. 

Irie Selkirk

Co-Founder

 

10+ years of visionary leadership in the wellness, psychedelics, and cannabis industries, specializing in integrating these fields with mainstream healthcare and pharmaceutical practices

Founder of Rise Wellness, the world’s first micro-dose psilocybin retreat providing clients with psychedelic-assisted therapies

Co-inventor of GCAP001, GoodCap’s lead drug candidate

Expert stakeholder providing advisory services to drug policy reform focused on psychedelics in multiple countries

Lorne Gertner, BArch, ICD.D, MRIAC

Director

 

Serial entrepreneur at the lead of emerging industries

Co-founder of Cynapsus Therapeutics which was acquired for $841 million

Co-founded and is the former chairman of PharmaCan (later known as Cronos), which achieved a peak market capitalization of $7 billion

Co-founder of the Tokyo Smoke brand which is now owned by Canopy Growth after a purchase in 2018 for $542 million

Daniels Faculty of Architecture, Landscape, and Design at the University of Toronto

Portrait of Dr. Darryl Hudson

Darryl Hudson

Co-founder and Chief Innovation Officer

 

Deep expertise in molecular biology, neuroscience and genetics in psychedelics

Prior to founding GoodCap, Darryl co-founded InPlanta Biotechnology Inc. and Pathways Rx, where he led the development and commercialization of proprietary plant genetics

PhD in molecular biology and genetics from the University of Guelph

Ralph Landau

Chief Science Officer

 

30+ years executive leadership in pharmaceutical R&D, manufacturing and operations

Sandoz, Novartis, Merck, Elan, Fougera, Cambrex

Led the commercialization of over 50 products covering a number of dosage forms, including Veregen, the first ever botanical drug approved by the FDA

Ph.D., Chemical Engineering, from the University of Delaware

Bachelor of Science, Chemical Engineering, from the New Jersey Institute of Technology

Andrew Williams, MBA

Chief Financial Officer

 

17+ years in the Pharma/Biotech sector as a Chief Financial Officer with extensive start-up, strategic, financial and operational experience

Was the COO & CFO of Cynapsus Therapeutics, a specialty CNS pharmaceutical company that developed Kynmobi®, a sublingual thin film strip for the treatment of OFF episodes associated with Parkinson’s disease

In October 2016, Cynapsus was acquired for $841 million by Sunovion Pharmaceuticals

While serving as CFO, Cynapsus raised approximately $170 million via private and public offerings, including $90 million from the proceeds of a US Initial Public Offering and NASDAQ listing.

BAH Economics from Queen’s University and MBA from Ivey School of Business at Western University

Rochelle Stenzler, BSc Phm, ICD.D

Chair of Board

 

35+ years senior executive and board experience in Pharma/healthcare

Fmr. President/CEO Pharma Plus Drugmarts, Revlon Canada, TLC Laser Eye Centers and TouchLogic Corporation

Chair of Cynapsus Therapeutics which was acquired for $841million

Fmr. Director & Vice Chair of the Humber River Hospital

BScPhm, Pharmacy, University of Toronto

Theresa Matkovits, PhD

Director

 

20+ years experience as leader in global drug development and commercialization

Experience across multiple therapeutic areas including Endocrine Disorders, Anti-infectives, Antivirals, Central Nervous System Disorders (Schizophrenia, Bipolar Disorders, Generalized Anxiety Disorders, Major Depression, Migraine, Anesthesia), Women’s Health, as well as a number of orphan indications

Board Director in private and public-sector companies

Doctor of Philosophy (Ph.D.), Biochemistry and Molecular Biology, University of Medicine and Dentistry of New Jersey

Joseph Elliot, MSc, PhD

Director

 

More than 30 years as a serial entrepreneur and former venture capitalist

Broad experience pharmaceuticals, biologicals and vaccines in oncology and infectious diseases

Experienced in drug development, manufacturing, regulatory affairs (FDA, EMA, NICE, Health Canada, WHO and BfArM)

Held senior technical and international marketing positions with Pharmacia Canada Inc. (now Pfizer) and Connaught Laboratories Inc (now Sanofi-Pasteur Vaccines)

PhD in Medical Sciences from McMaster University

Carol Coughlin, MBA

Director, Chair of FAR Committee

 

20+ years experience as CFO specializing in healthcare

Experienced public company board leader, audit committee chair, and is highly skilled in corporate governance including board refreshment, strategic alternatives and M&A for growth and highly regulated companies

Loyola University in MD (MBA) and Towson University (BS Business), is a Board Leadership Fellow (NACD) and a Certified Public Accountant (active status)

Robert Dantzer, PhD, DVM

Professor in the Department of Symptom Research in the Division of Internal Medicine at The University of Texas MD Anderson Cancer Center, Houston, Texas

A pioneer in establishing the connection between depression and inflammation

Current research aims at understanding the role of inflammation and mitochondrial dysfunction in the pathophysiology of depression and fatigue

Authored more than 550 original research papers, reviews and book chapters on stress, anxiety, neuropeptides, brain-immune interactions, and inflammation-associated depression

H.G.J.M. Vermetten PhD, MD

Clinical psychiatrist and Faculty member of the Department of Psychiatry at Leiden University in the Netherlands with 20+ years of experience working with veterans and other uniformed officers as Head of Research at the Military Mental Health Service with the Dutch Ministry of Defense and was affiliated with ARQ National Psychotrauma Center. He also has an Adjunct Professorship at the Department of Psychiatry of New York UMC.

Author of 300+ scientific papers and 40+ book chapters, plus additional book edits. Leading the landmark 10-year PRISMO study on military operations, he offered insights into PTSD. 

Trained in the Netherlands as well as in the USA in psychiatry and neuroscience (Stanford, Yale, and Emory University). He has a clinical as well as a research position with a focus on medical/biological as well as psychiatric aspects of complex psychotrauma in military as well as civilian populations. Renowned for pioneering work in novel drug developments, particularly MDMA, psilocybin, ketamine, and medical cannabis.

Charles B. Nemeroff, PhD, MD

Chair and professor with the Department of Psychiatry and Behavioral Sciences at the University of Texas at Austin

Co-director of the Center for Psychedelic Research and Therapy

Directs the Institute for Early Life Adversity Research within the Department of Psychiatry and Behavioral Sciences as part of the Mulva Clinic for the Neurosciences

Former Chair of the Department of Psychiatry and Behavioral Sciences and clinical director of the Center on Aging at the University of Miami Miller School of Medicine

Laura Targownik, PhD, MD

Clinician Researcher in the Mount Sinai Hospital Inflammatory Bowel Disease Clinic. Director for the University of Toronto Division of Gastroenterology and Hepatology and a faculty member of the University of Toronto School of Public Health Institute for Health Policy, Management and Evaluation.

Founder of the Ontario Best Practices Research Initiative in IBD, Ontario’s premier source of real-world data and patient-reported data on IBD in Ontario. Authored or co-authored over 180 articles in peer-reviewed publications.

Current research focus on the costs and benefits of medications used in IBD, assessing how to optimize delivery of mental health care for persons with IBD in diverse practice settings.

Elizabeth Nielson, PhD

Co-founder of Fluence and a psychologist with a focus on developing psychedelic medicines as empirically supported treatments for mood disorders, PTSD, and substance use problems. 

Site Co-Principal Investigator and therapist for an FDA approved Phase 3 clinical trial of psychedelic-assisted Psychotherapy and has served as a therapist on earlier FDA approved clinical trials of psilocybin-assisted treatments for treatment resistant depression. 

Assistant Professor of Clinical Medical Psychology in Psychiatry and Project Clinician at Columbia University where her research includes qualitative and mixed-methods projects to further understand the phenomenology and mechanisms of change in psychedelic-assisted therapy.

Ken Croitoru, PhD, MD

Professor of Medicine at the University of Toronto, where he is a member of the Institute of Medical Science and secondarily appointed to the Department of Immunology

Gastroenterologist and internist at Mount Sinai Hospital in Toronto, Canada with 35+ years of experience in medical practice, teaching, and research focused on gut inflammation

Worked extensively with the Crohn’s and Colitis Foundation of Canada where he helped to develop the IBD Research Institute, and is now a project leader of the GEM Project, a global clinical study coordinated out of the IBD research group at the Zane Cohen Centre at Mount Sinai Hospital

Cory Weissman, MD​

Head of Interventional Psychiatry at UC San Diego, focusing on the development of novel treatments, including psychedelic medicines, for patients with severe mental illness

Highly active in the field of psychedelic science, where he has published on psychedelic microdosing and led several studies investigating the potential use of psychedelics for suicidality

Former clinical and research fellow in brain stimulation at the University of Toronto 

Barbara Olasov Rothbaum, PhD, MD

Clinical researcher in Atlanta, USA with 37+ years of experience in medical practice, teaching, and research focused on Post-Traumatic Stress Disorder.

Author of 400+ scientific papers and chapters and served as Associate Editor of The Journal of Traumatic Stress.

Blue Ribbon Panel Member for Pentagon officials, consultant to the Department of Defense, and Member of the Institute of Medicine’s (IOM) Study on Assessment of Ongoing Efforts in the Treatment of PTSD

Professor of Psychiatry and Behavioral Sciences at the medical school of a high-ranking University in Atlanta, where she is a director of the Trauma and Anxiety Recovery Program and the Associate Vice Chair of Clinical Research.

Portrait of Steve Sadoff

Steven Sadoff

Co-founder and Chief Executive Officer

 

15+ years of leadership experience across highly regulated industries with 100+ innovative product launches

Proven track record of growing sales, building brands, and leading product-development teams for Bacardi, Labatt, Novartis, and Jamieson Laboratories